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SUMMARY
There was a change in pattern ofand increased prevalence ofcervical cancer in
Northern Ireland from 1965 to 1989, characterised by an increased incidence
in women under 40 years. These changes occurred despite special screening of
younger women, although the screening programme has probably prevented an
even greater increase in incidence of the disease. To reduce the incidence of
cervical cancer, not only systematic screening but also cervical smears at more
frequent intervals would be required.
INTRODUCTION
Community cervical screening commenced in a random fashion in Northern
Ireland in 1965. The effect of this screening on the incidence or mortality from
cervical cancer is unknown, as the registration of cancer, especially of the cervix,
is very incomplete in the province.' We therefore assessed the incidence of
cervical cancer in Northern Ireland from 1965 to 1989 by a study of biopsy
records to determine the impact of 25 years of cervical screening on changes in
the pattern of the disease.
METHODS
Biopsy reports of all cases of cervical cancer occurring in Northern Ireland from
1965 to 1989 were reviewed in a survey ofthe records ofthe four histopathology
laboratories in the province. Microinvasive cases were excluded, and invasive
cases included only when the depth of invasion was considered by the histo-
pathologist to be more than 5 mm. This decision was made because it became
clear that in an appreciable number of biopsies intraepithelial neoplasia involving
the endocervical crypts wasdifficult todifferentiate from microinvasion, especially
if there was an associated inflammatory reaction. There was also a marked
variation in the frequency with which microinvasion was reported between
different laboratories, also reflecting this difficulty in interpretation. Cases of
adenocarcinoma were only included ifthe pathologist considered that the tumour
was definitely cervical rather than endometrial in origin. During the study other
potential sources of inaccuracy became apparent. In some cases the distinction
between microinvasive and fully invasive disease was not clear from the report.
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In others, carcinoma secondary to the cervix had been miscoded as primary
cervical cancer, or diagnostic problems arose because the patient had a history of
carcinoma in another organ. Whenever possible any uncertainty in diagnosis was
resolved by a review of the biopsy or examination of the patient's hospital notes.
By these means patients were grouped according to their year of diagnosis, age
and the histological type of the tumour. In 37 cases (2-4%) the patient's age
could not be determined and these cases were excluded.
RESULTS
The age-specific incidence rates of cervical cancer, excluding microinvasive
cases, for five year periods from 1965 - 89 are shown in the Table. During the
period 1975 - 89, the incidence in women aged less than 40 has more than
doubled. The increase first affected those under 30 years, the rate not increasing
in those aged 30- 39 until 1980. From 1975 - 89 cervical cancer declined in
those aged 45 - 59.
TABLE
Annual incidence rates of cervical cancer per million women according to age
group and period
Period
Age (years)
20 - 24
25 - 29
30- 34
35 - 39
40-44
45 -49
50 - 54
55 - 59
60-64
65 - 69
70- 74
75 - 79
80+
1965 - 9
0-0
17-7
28-1
92-2
155-7
174-3
251 -1
205-7
192-7
164-4
140-9
115-0
62-4
1970 - 4 1975 - 9 1980 - 4 1985 - 9
0-0
23-9
50-1
72-4
100-5
220-1
242-0
282-4
169-5
135-4
137-3
121-7
87-6
11-3
41-5
46-7
81-0
79-7
139-8
169-4
224-9
156-7
175-2
206-7
105-4
107-9
9-7
31 -1
99-4
101-4
157-9
137-2
179-4
195-5
198-1
182-5
116-4
61- 7
68-7
12-4
34-1
108-5
162-5
208-3
107-0
155-6
174-4
221 -6
243-3
180-9
136-0
84-0
The histological type of cervical cancer according to age group for each five year
period is shown in the Figure. From 1965 to 1989 about 10% of all the cervical
cancers in each five year period were adenocarcinomas or adenosquamous
tumours. In 1980 - 84 there was a fivefold increase in adenocarcinoma affecting
women aged less than 45 years compared to 1965 -79. This increase was most
marked in the 20- 39 year age group. This increased incidence became even
more marked in 1985 - 89 when adenocarcinoma occurred about eight times
more frequently in those under 45 years, and in women aged 20 - 39 years these
tumours constituted almost 20% of carcinomas.
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Figure. Distribution of histological types of carcinoma according to age groups and period. Adeno-
carcinoma includes 10% of adenosquamous tumours. Undifferentiated carcinomas are included with
thesquamous tumours. Thefigures ontopofthecolumnsindicatethe numberofeach histological type.
DISCUSSION
In 1989 there were 547,941 women aged 20 years and over resident in Northern
Ireland. Although this survey is based on a smaller population than those dealing
with cervical cancer in Britain, its precision is increased by being based on biopsy
reports. Northern Ireland is also a relatively discrete geographic area and is
less affected by cross-boundary population changes which can influence results
in larger regions. Moreover, most previous reports have relied on mortality
rates which are subject to diagnostic inaccuracy and incomplete registration.
Registration of cancer mortality varies in its completeness in Britain and,
as in Northern Ireland, cervical cancer deaths are probably especially poorly
recorded.1 2
Our results clearly show that since 1975 there has been a very marked change
in the pattern of cervical cancer, characterised by an increased incidence of
squamous carcinoma in young women followed five years later by a striking
increase in adenocarcinoma in the same age groups. A similar increase in
mortality rate among younger women was noted in England and Wales3 but the
corresponding rise in incidence rates appears to have occurred five or more years
earlier than in Northern Ireland. Almost certainly incidence rates in the province
would have been appreciably higher in the absence of screening. Our results, for
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example, do not include microinvasive cases which were detected by cervical
smear and prevented from progressing. Also, from 1965-89 this laboratory
detected moderate or severe dyskaryosis in about 4,600 women, which if
untreated would also have increased the cancer incidence rate.
It is particularly disappointing to find that the incidence of cervical cancer in
Northern Ireland has not decreased among younger women. During the 25 years
of screening we estimate that about 1 25 million cervical smears have been
examined in the province and a laboratory survey shows that 67% of these were
from women 20-39 years old, a population comprising 226,194 in 1989.
Despite this intensive screening effort it is women of this age group who are now
showing a rising cancer incidence. Twenty years ago, in 1971 Brown and Lynch
reported a population survey in the province which showed that even then 40%
of women under 40 years had been screened at least once.4 In Britain it was
estimated that by 1981 nearly 80% of women under 35 years were being
screened.5
Our results suggest some possible causes for this relative failure of screening.
The incidence rates clearly indicate that the screening programme was being
conducted in the face of an increasing rate of occurrence of cervical cancer,
probably more pronounced thanindicated byourincidence rates. Alsoofconcern
is the relatively marked increase in the proportion of adenocarcinoma in younger
women. These tumours are much harder to detect than squamous carcinoma in
their preinvasive stages. This change in pattern of adenocarcinoma might reflect
an underlying change in the biology of the disease which if associated with a
shortened intraepithelial phase of squamous tumours would make them more
difficult to detect by screening. Such a possibility has been suggested by others
but so far not substantiated.6
Two other aspects of the screening programme in Northern Ireland could well be
of importance in its relative failure. It was random in nature and probably less
effective in attracting those young women most at risk, but a gross failure in this
respect would be required to account for our results. Furthermore, doctors and
patients were advised that smears should be repeated at five year intervals.
Although even a single negative smear has been said to have considerable
protective value,7'8 there is evidence that false negative smears are not infrequent
and that the protection given by one negative result is relatively low.9' 10 Our
findings show that random screening has been inadequate in the prevention
of cervical cancer in Northern Ireland and we feel that even with systematic
screening, a five year interval between smears will prove too long to counter an
increasing incidence of disease.
We hope that a current study of the screening history with review of cervical
smears from all those who developed cervical cancer from 1982 - 89 will provide
more insight into some of these issues.
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